Vietnam Tuberculosis Therapeutics Market, By Disease Type (Active Tuberculosis v/s Latent Tuberculosis), By Therapy (First Line Therapy v/s Second Line Therapy), By Region, Competition Forecast & Opportunities, 2028

The Vietnam tuberculosis therapeutics market is anticipated to register a robust growth in the forecast period, 2023-2027. Growing demands for effective treatment and efficient pharmaceuticals to control the growing instances of tuberculosis is driving the market growth. Besides, increasing investments and grants for tuberculosis therapeutics are boosting the growth of the Vietnam tuberculosis therapeutics market. Earlier, tuberculosis has been a leading cause of death in Vietnam. The government is aggressively implementing programs and initiatives to control the tuberculosis rates such as the National Tuberculosis Control Programme (NTP). Rising government measures and growing public awareness of communicable illnesses are also expected to fuel the Vietnam tuberculosis therapeutics market. Rising incidences of drug susceptible tuberculosis and increase in multi-drug resistant TB cases are some of the factors boosting the market growth. Besides. More R&D efforts towards drug development, emergence of effective drug alternatives in the market, and collaborations focused on the development of shorter treatment regimens to fight resistance and address unmet medical needs, which are expected to fuel the market growth.

The Vietnam tuberculosis therapeutics market is segmented on the basis of disease type, therapy, competitive landscape, and regional distribution. Based on disease type, the market is divided between active tuberculosis and latent tuberculosis. The most common cause of tuberculosis in the general population is Mycobacterium tuberculosis. The prevalence of Mycobacterium tuberculosis in South Asian nations like Vietnam, India, Laos, etc., is a significant contributor to the rise in tuberculosis cases and, consequently, the demand for tuberculosis medicines. Active tuberculosis patients have a propensity to spread the illness to others. Patients with latent tuberculosis, however, do not have this tendency.

The major market players operating in the Vietnam tuberculosis therapeutics market are Novartis Vietnam Co., Ltd., Johnson & Johnson, Otsuka Pharmaceutical Vietnam JSC, Lupin Limited, and GSK Vietnam.

Years considered for this report:

• Historical Years: 2017-2020
• Base Year: 2021
• Estimated Year: 2022
• Forecast Period: 2023-2027

Objective of the Study:

• To analyze the historical growth in the market size of the Vietnam tuberculosis therapeutics from 2017 to 2021.
• To estimate and forecast the market size of Vietnam tuberculosis therapeutics market from 2023 to 2027 and growth rate until 2027.
• To classify and forecast the Vietnam tuberculosis therapeutics market based on disease type, therapy, region, and company.
• To identify the dominant region or segment in the Vietnam tuberculosis therapeutics market.
• To identify drivers and challenges for the Vietnam tuberculosis therapeutics market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Vietnam tuberculosis therapeutics market.
• To identify and analyze the profiles of leading players operating in the Vietnam tuberculosis therapeutics market.
• To identify key sustainable strategies adopted by market players in Vietnam tuberculosis therapeutics market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of service providers across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the service providers who could not be identified due to the limitations of secondary research. The publisher analyzed service providers and presence of all major players across the country.

The publisher calculated the market size of the Vietnam tuberculosis therapeutics market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Vietnam tuberculosis therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Vietnam Tuberculosis Therapeutics Market, By Disease Type:

• Active Tuberculosis
• Latent Tuberculosis

Vietnam Tuberculosis Therapeutics Market, By Therapy:

• First Line Therapy
• Second Line Therapy

Vietnam Tuberculosis therapeutics Market, By Region:

• Northern Region
• Central Region
• Southern Region

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Vietnam tuberculosis therapeutics market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.